Insider Transactions in Q4 2023 at Solid Biosciences Inc. (SLDB)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2023
|
Alexander Cumbo President and CEO |
SELL
Open market or private sale
|
Direct |
11,757
-40.27%
|
$23,514
$2.77 P/Share
|
|
Dec 04
2023
|
Jennifer Marlowe CSO |
SELL
Open market or private sale
|
Direct |
4,890
-41.13%
|
$9,780
$2.77 P/Share
|
|
Dec 04
2023
|
Jessie Hanrahan Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
4,879
-41.13%
|
$9,758
$2.78 P/Share
|
|
Dec 04
2023
|
Paul Herzich Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,968
-41.01%
|
$5,936
$2.77 P/Share
|
|
Dec 04
2023
|
David T Howton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,367
-41.12%
|
$10,734
$2.78 P/Share
|
|
Dec 02
2023
|
Alexander Cumbo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,612
+49.49%
|
-
|
|
Dec 02
2023
|
Jennifer Marlowe CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,888
+50.0%
|
-
|
|
Dec 02
2023
|
Jessie Hanrahan Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,862
+50.0%
|
-
|
|
Dec 02
2023
|
Paul Herzich Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,238
+50.0%
|
-
|
|
Dec 02
2023
|
David T Howton Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,051
+50.0%
|
-
|
|
Dec 02
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
1,583
+1.71%
|
-
|
|
Oct 03
2023
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,569
+15.58%
|
-
|